Retatrutide Trial Shows Weight Loss Reaches Twenty-Five Percent in Late-Stage Data

By Beth Mole · Ars Technica · 2026-09-29

Retatrutide Trial Shows Weight Loss Reaches Twenty-Five Percent in Late-Stage Data

Ars Technica reports that latest results for the obesity drug retatrutide demonstrate significant efficacy, with patients on the highest dosage losing a quarter of their body weight on average. These findings from the New England Journal of Medicine suggest the treatment outpaces

Ars Technica reports that latest results for the obesity drug retatrutide demonstrate significant efficacy, with patients on the highest dosage losing a quarter of their body weight on average. These findings from the New England Journal of Medicine suggest the treatment outpaces